Goal Attainment Scaling in Upper Limb Spasticity Treatment
Goal Attainment Scaling in Upper Limb Spasticity Treatment With Botulinum Toxin and the Influence of Regular Exercise for Spastic Upper Limb on Quality of Life in Patients After Stroke
University Rehabilitation Institute, Republic of Slovenia
70 participants
Jan 3, 2021
INTERVENTIONAL
Conditions
Summary
Patients after stroke with upper limb spasticity treated with botulinum toxin-A (BTX-A) will be included in this two-part study. In the first part, goal attainment scaling and comprehensive assessment of motor functioning will be performed before BTX-A application and after two weeks. In the second part, the patients will be randomised into a test group performing prescribed regular exercise for two weeks and a control group exercising at their own discretion during the same period, whereby the patients' health-related quality of life will be assessed at the beginning and end of the two-week period.
Eligibility
Inclusion Criteria5
- patient's or caregiver's approval
- ischemic or hemorrhagic stroke diagnosed using head CT/MRI
- at least one upper limb muscle spasticity (MAS ≥ 3)
- candidate for BTX-A treatment or already given BTX-A in the past
- patient's or caregiver's capability for goal attainment protocol cooperation (Mini Mental Examination ≥ 24 points)
Exclusion Criteria2
- aphasic patients without caregiver's presence
- other neurological or musculoskeletal diseases that could affect the treatment outcome
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Active or passive exercises for the spastic upper limb, including functional electrical stimulation (FES), performed regularly for two weeks.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04975646